The outcomes of esophageal and gastric cancer treatments in a retrospective study, single center experience

International Journal of Hematology-Oncology and Stem Cell Research

Volumn 8, Issue 2, 2014, Pages 9-13

  Alimoghaddam, Kamran ^a   Jalali, Arash ^a   Aliabadi, Leyla Sharifi ^a   Ghaffari, Fatemeh ^a   Maheri, Roghieh ^a   Eini, Ezzat ^a   Mashhadireza, Maryam ^a   Mousavi, Seied Asadollah ^a   Bahar, Babak ^a   Jahani, Mohammad ^a   Ghavamzadeh, Ardeshir ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Esophageal cancer; Gastric cancer; Survival analysis

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; ESOPHAGUS CANCER; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; GASTROESOPHAGEAL JUNCTION CANCER; HUMAN; IRAN; LOWER ESOPHAGUS SPHINCTER; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RETROSPECTIVE STUDY; STOMACH CANCER;

EID: 84898761723     PISSN: 17351243     EISSN: 20082207     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA Cancer J Clin. 2005;55:74-108
2. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, aninternational perspective. Asian Pac J Cancer Prev. 2005; 6: 359-63
3. Sadjadi A, Malekzadeh R, Derakhshan MH, Sepehr A, Nouraie M, Sotoudeh M, et al. Cancer occurrence in Ardabil: results of apopulation-based cancer registry from Iran. Int J Cancer. 2003; 107:113-8.
4. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. The New England journal of medicine. 1999;340(11):825-31.
5. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Annals of internal medicine. 1999;130(11):883-90.
6. Samadi F, Babaei M, Yazdanbod A, Fallah M, Nouraie M, Nasrollahzadeh D, et al. Survival rate of gastric and esophageal cancers in Ardabil province, North-West of Iran. Archives of Iranian medicine. 2007;10(1):32-7.
7. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. The New England journal of medicine. 2001;345(10):725-30.
8. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. The New England journal of medicine. 2006;355(1):11-20.
9. Wagner AD, Unverzagt S, Grothe W, Kleber G, Grothey A, Haerting J, et al. Chemotherapy for advanced gastric cancer. Cochrane database of systematic reviews (Online). 2010(3):CD004064.
10. Adachi Y, Mori M, Maehara Y, Sugimachi K. Long-term survival after resection for advanced gastric carcinoma. Journal of clinical gastroenterology. 1995;21(3):208-10.
11. Morteza Bashash & Parvin Yavari & T. Greg Hislop & Amil Shah & Alireza Sadjadi & Masoud Babaei & Nhu Le & Angela Brooks-Wilson & Reza Malekzadeh & Chris Bajdik. Comparison of Two Diverse Populations, British Columbia, Canada, and Ardabil, Iran, Indicates Several VariablesAssociated with Gastric and Esophageal Cancer Survival. Gastrointest Canc (2011) 42:40-45
12. Kunz PL, Gubens M, Fisher GA, Ford JM, Lichtensztajn DY, Clarke CA. Long-term survivors of gastric cancer: a California population-based study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2012;30(28):3507-15.